Dong Hyun Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dong Hyun Kim has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Byung-Tae Kim
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, Republic of Korea
7 shared publicationsKyung-Han Lee
7 shared publications- Yearn Seong Choe
Department of Nuclear Medicine, Samsung Medical Center
6 shared publications Yong Choi
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, Korea
6 shared publicationsJoon Young Choi
3 shared publicationsByung Chul Lee
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, Korea
2 shared publications
Latest Publications
- 22 May 2022
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 108-109, S127-S128
Automated synthesis and quality control of [18F]FFNP with GMP compliance
- 22 May 2022
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 108-109, S127-S128
Automated synthesis and quality control of [18F]FFNP with GMP compliance
- Open Access
- 10 September 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0257439
Correction: PINK1 alleviates thermal hypersensitivity in a paclitaxel-induced Drosophila model of peripheral neuropathy
[This corrects the article DOI: 10.1371/journal.pone.0239126.].
- 10 September 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0257439
Open AccessCorrection: PINK1 alleviates thermal hypersensitivity in a paclitaxel-induced Drosophila model of peripheral neuropathy
[This corrects the article DOI: 10.1371/journal.pone.0239126.].
- Open Access
- 25 June 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Light-Triggered Radiochemical Synthesis: A Novel 18F-Labelling Strategy Using Photoinducible Click Reaction to Prepare PET Imaging Probes
Novel probe development for positron emission tomography (PET) is leading to expanding the scope of molecular imaging. To begin responding to challenges, several biomaterials such as natural products and small molecules, peptides, engineered proteins including affibodies, and antibodies have been used in the development of targeted molecular imaging probes. To prepare radiotracers, a few bioactive materials are unique challenges to radiolabelling because of their complex structure, poor stability, poor solubility in aqueous or chemical organic solutions, and sensitivity to temperature and nonphysiological pH. To overcome these challenges, we developed a new radiolabelling strategy based on photoactivated 1,3-dipolar cycloaddition between alkene dipolarophile and tetrazole moiety containing compounds. Herein, we describe a light-triggered radiochemical synthesis via photoactivated click reaction to prepare 18F-radiolabelled PET tracers using small molecular and RGD peptide.
- 25 June 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Open AccessLight-Triggered Radiochemical Synthesis: A Novel 18F-Labelling Strategy Using Photoinducible Click Reaction to Prepare PET Imaging Probes
Novel probe development for positron emission tomography (PET) is leading to expanding the scope of molecular imaging. To begin responding to challenges, several biomaterials such as natural products and small molecules, peptides, engineered proteins including affibodies, and antibodies have been used in the development of targeted molecular imaging probes. To prepare radiotracers, a few bioactive materials are unique challenges to radiolabelling because of their complex structure, poor stability, poor solubility in aqueous or chemical organic solutions, and sensitivity to temperature and nonphysiological pH. To overcome these challenges, we developed a new radiolabelling strategy based on photoactivated 1,3-dipolar cycloaddition between alkene dipolarophile and tetrazole moiety containing compounds. Herein, we describe a light-triggered radiochemical synthesis via photoactivated click reaction to prepare 18F-radiolabelled PET tracers using small molecular and RGD peptide.
- 22 April 2014
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (9) , 3678-3686
Preparation and Evaluation of Fluorine-18-Labeled Insulin as a Molecular Imaging Probe for Studying Insulin Receptor Expression in Tumors
A convenient emulsion-based labeling method was used to synthesize fluorine-18-labeled insulin specifically B1-(4-[18F]fluorobenzoyl)insulin (18F-4b) in 6% overall radiochemical yield in 240 min. In vitro screening in MCF7 breast cancer cells demonstrated that the nonradioactive analogue 19F-4a effectively competed with 125I-insulin for the insulin receptor (IC50 = 10.6 nM) comparable to that for insulin (IC50 = 7.4 nM). 18F-4b was also more stable than 125I-insulin in mouse plasma with 50% remaining intact after 30 min. A biodistribution study in normal mice showed initial uptake of the tracer in the kidneys, liver, and gall bladder but rapid clearance via the urine/bladder which was also observed in murine models bearing insulin receptor positive tumors.
- 22 April 2014
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (9) , 3678-3686
Preparation and Evaluation of Fluorine-18-Labeled Insulin as a Molecular Imaging Probe for Studying Insulin Receptor Expression in Tumors
A convenient emulsion-based labeling method was used to synthesize fluorine-18-labeled insulin specifically B1-(4-[18F]fluorobenzoyl)insulin (18F-4b) in 6% overall radiochemical yield in 240 min. In vitro screening in MCF7 breast cancer cells demonstrated that the nonradioactive analogue 19F-4a effectively competed with 125I-insulin for the insulin receptor (IC50 = 10.6 nM) comparable to that for insulin (IC50 = 7.4 nM). 18F-4b was also more stable than 125I-insulin in mouse plasma with 50% remaining intact after 30 min. A biodistribution study in normal mice showed initial uptake of the tracer in the kidneys, liver, and gall bladder but rapid clearance via the urine/bladder which was also observed in murine models bearing insulin receptor positive tumors.
- 14 February 2014
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (12) , 4545-4553
Effect of space length of mannose ligand on uptake of mannosylated liposome in RAW 264.7 cells:In vitroandin vivostudies
- 14 February 2014
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (12) , 4545-4553
Effect of space length of mannose ligand on uptake of mannosylated liposome in RAW 264.7 cells:In vitroandin vivostudies
- 25 April 2012
- Published by Wiley in Chemistry – A European Journal
- Vol. 18 (22) , 6746-6749
Emulsion Reactors: A New Technique for the Preparation of Molecular Imaging Probes
- 25 April 2012
- Published by Wiley in Chemistry – A European Journal
- Vol. 18 (22) , 6746-6749
Emulsion Reactors: A New Technique for the Preparation of Molecular Imaging Probes
- Open Access
- 10 February 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2) , e25936
Trans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage
Radiation therapy is an indispensable therapeutic modality for various brain diseases. Though endogenous neural stem cells (NSCs) would provide regenerative potential, many patients nevertheless suffer from radiation-induced brain damage. Accordingly, we tested beneficial effects of exogenous NSC supplementation using in vivo mouse models that received whole brain irradiation. Systemic supplementation of primarily cultured mouse fetal NSCs inhibited radiation-induced brain atrophy and thereby preserved brain functions such as short-term memory. Transplanted NSCs migrated to the irradiated brain and differentiated into neurons, astrocytes, or oligodendrocytes. In addition, neurotrophic factors such as NGF were significantly increased in the brain by NSCs, indicating that both paracrine and replacement effects could be the therapeutic mechanisms of NSCs. Interestingly, NSCs also differentiated into brain endothelial cells, which was accompanied by the restoration the cerebral blood flow that was reduced from the irradiation. Inhibition of the VEGF signaling reduced the migration and trans-differentiation of NSCs. Therefore, trans-differentiation of NSCs into brain endothelial cells by the VEGF signaling and the consequential restoration of the cerebral blood flow would also be one of the therapeutic mechanisms of NSCs. In summary, our data demonstrate that exogenous NSC supplementation could prevent radiation-induced functional loss of the brain. Therefore, successful combination of brain radiation therapy and NSC supplementation would provide a highly promising therapeutic option for patients with various brain diseases.
- 10 February 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2) , e25936
Open AccessTrans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage
Radiation therapy is an indispensable therapeutic modality for various brain diseases. Though endogenous neural stem cells (NSCs) would provide regenerative potential, many patients nevertheless suffer from radiation-induced brain damage. Accordingly, we tested beneficial effects of exogenous NSC supplementation using in vivo mouse models that received whole brain irradiation. Systemic supplementation of primarily cultured mouse fetal NSCs inhibited radiation-induced brain atrophy and thereby preserved brain functions such as short-term memory. Transplanted NSCs migrated to the irradiated brain and differentiated into neurons, astrocytes, or oligodendrocytes. In addition, neurotrophic factors such as NGF were significantly increased in the brain by NSCs, indicating that both paracrine and replacement effects could be the therapeutic mechanisms of NSCs. Interestingly, NSCs also differentiated into brain endothelial cells, which was accompanied by the restoration the cerebral blood flow that was reduced from the irradiation. Inhibition of the VEGF signaling reduced the migration and trans-differentiation of NSCs. Therefore, trans-differentiation of NSCs into brain endothelial cells by the VEGF signaling and the consequential restoration of the cerebral blood flow would also be one of the therapeutic mechanisms of NSCs. In summary, our data demonstrate that exogenous NSC supplementation could prevent radiation-induced functional loss of the brain. Therefore, successful combination of brain radiation therapy and NSC supplementation would provide a highly promising therapeutic option for patients with various brain diseases.
- 1 May 2011
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 38 (4) , 541-547
Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies
- 1 May 2011
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 38 (4) , 541-547
Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies
- 1 February 2010
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 68 (2) , 329-333
Evaluation of 4-[18F]fluoro-1-butyne as a radiolabeled synthon for click chemistry with azido compounds
- 1 February 2010
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 68 (2) , 329-333
Evaluation of 4-[18F]fluoro-1-butyne as a radiolabeled synthon for click chemistry with azido compounds
- 26 May 2009
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 20 (6) , 1139-1145
17-[4-(2-[18F]Fluoroethyl)-1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic Acid: A Potential Radiotracer for the Evaluation of Myocardial Fatty Acid Metabolism
In this study, we synthesized 17-[4-(2-[18F]fluoroethyl)−1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic acid ([18F]1), a PET radiotracer for the evaluation of fatty acid metabolism. [18F]1 was synthesized in 20−26% decay-corrected radiochemical yields from 17-azido 6-thia-heptadecanoic acid (9) and 4-[18F]fluoro-1-butyne using click chemistry. The tissue distribution of [18F]1 in mice showed high radioactivity accumulation in heart (3.70%ID/g at 1 min, 3.28%ID/g at 10 min, and 3.01%ID/g at 60 min postinjection), a prolonged myocardial elimination half-life (>60 min), and a maximal heart-to-blood uptake ratio at 5 min postinjection (5.55). Pretreatment with etomoxir, a carnitine palmitoyl transferase (CPT) I inhibitor, reduced myocardial radioactivity uptake at 30 min postinjection by 53%, suggesting that [18F]1 was transported into the mitochondria. Analyses of heart tissue samples showed that most of the radioactivity was present in a tissue pellet (62−63%) after homogenization in CHCl3−CH3OH followed by extraction with 40% urea and 5% H2SO4, which was mostly precipitated with addition of 50% trichloroacetic acid (TCA). These results suggest that [18F]1 undergoes metabolic trapping via β-oxidation in myocardium and, thus, suggest that it has potential use as a PET radiotracer for the evaluation of myocardial fatty acid metabolism.
- 26 May 2009
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 20 (6) , 1139-1145
17-[4-(2-[18F]Fluoroethyl)-1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic Acid: A Potential Radiotracer for the Evaluation of Myocardial Fatty Acid Metabolism
In this study, we synthesized 17-[4-(2-[18F]fluoroethyl)−1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic acid ([18F]1), a PET radiotracer for the evaluation of fatty acid metabolism. [18F]1 was synthesized in 20−26% decay-corrected radiochemical yields from 17-azido 6-thia-heptadecanoic acid (9) and 4-[18F]fluoro-1-butyne using click chemistry. The tissue distribution of [18F]1 in mice showed high radioactivity accumulation in heart (3.70%ID/g at 1 min, 3.28%ID/g at 10 min, and 3.01%ID/g at 60 min postinjection), a prolonged myocardial elimination half-life (>60 min), and a maximal heart-to-blood uptake ratio at 5 min postinjection (5.55). Pretreatment with etomoxir, a carnitine palmitoyl transferase (CPT) I inhibitor, reduced myocardial radioactivity uptake at 30 min postinjection by 53%, suggesting that [18F]1 was transported into the mitochondria. Analyses of heart tissue samples showed that most of the radioactivity was present in a tissue pellet (62−63%) after homogenization in CHCl3−CH3OH followed by extraction with 40% urea and 5% H2SO4, which was mostly precipitated with addition of 50% trichloroacetic acid (TCA). These results suggest that [18F]1 undergoes metabolic trapping via β-oxidation in myocardium and, thus, suggest that it has potential use as a PET radiotracer for the evaluation of myocardial fatty acid metabolism.